glp-1 obesity drug news oct 21 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ New GLP-1 Pill Foundayo (Orforglipron)

Medical concepts are systematically categorized using the Medical Dictionary for Regulatory Activities (MedDRA) terminology, with Preferred Terms (PTs) representing granular AE descriptions, hierarchically grouped into High-Level Terms (HLTs), High-Level Group Terms (HLGTs), and System Organ Classes (SOCs) 18,19

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al

Results of a review by the European Medicines Agency (EMA) show no evidence that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are linked to suicidal and self-injurious thoughts

This creates a state of persistent psychological tension that eventually exhausts most dieters

Ive got you

For the time being, tirzepatide remains the superior option for many people thinking about GLP-1 therapy for their obesity or type 2 diabetes, though it does tend to cost more than semaglutide